Here’s Why Mobileye, Fitbit, & More are in the Red Today

Gladstone Capital Corporation (NASDAQ:GLAD) is 11.6% in the red on abnormally high trading volume as sentiment around the externally-managed, closed-end, non-diversified management investment company heads south. As a business development company, Gladstone Capital Corporation (NASDAQ:GLAD) has extended $5 million-to-$30 million debt loans to small and medium-sized businesses in the United States, some of which have been badly hurt by the falling oil and gas prices. Investors could be selling Gladstone on the fear that its net asset value will be worse than expected because of the energy price collapse. Three elite funds that we track held about 0.6% of the company’s float at the end of the third quarter.

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) shares are 5% lower today as sentiment around the biotech company remains sharply negative. Although there is no specific news event causing today’s poor performance, momentum selling could have something to do with it, as ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) has steadily retreated from the $12 level in early December. Hedge funds are growing less optimistic too, as the number of top shareholders fell by six quarter-over-quarter to nine as of September 30.

Disclosure: None